Arcutis Biotherapeutics Stock Target Price and Analyst Consensus
| ARQT Stock | USD 14.55 0.21 1.46% |
The current analyst and expert consensus on Arcutis Biotherapeutics is Strong Buy, with 4 strong buy opinions. The current projected Arcutis Biotherapeutics target price consensus is 21.14 with 7 analyst opinions. Check out Macroaxis Advice on Arcutis Biotherapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.The most common way Arcutis Biotherapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Arcutis Biotherapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Arcutis Biotherapeutics. We strongly encourage you to use your own analysis of Arcutis Biotherapeutics to validate this buy or sell advice. Arcutis Biotherapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Arcutis Biotherapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.0185.
Lowest Forecast 19.24 | Highest Forecast 23.47 | Target Price 21.14 |
It's important to approach Arcutis Biotherapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Arcutis Biotherapeutics Target Price Consensus
Arcutis target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Arcutis Biotherapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Arcutis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Arcutis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Arcutis Biotherapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationArcutis Biotherapeutics Target Price Projection
Arcutis Biotherapeutics' current and average target prices are 14.55 and 21.14, respectively. The current price of Arcutis Biotherapeutics is the price at which Arcutis Biotherapeutics is currently trading. On the other hand, Arcutis Biotherapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Arcutis Biotherapeutics Market Quote on 23rd of July 2025
Target Price
Analyst Consensus On Arcutis Biotherapeutics Target Price
Arcutis Biotherapeutics Analyst Ratings
Arcutis Biotherapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Arcutis Biotherapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Arcutis Biotherapeutics' financials, market performance, and future outlook by experienced professionals. Arcutis Biotherapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Arcutis Biotherapeutics price targets
Arcutis Biotherapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Arcutis Biotherapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Arcutis Biotherapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Arcutis Biotherapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Arcutis Biotherapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arcutis Biotherapeutics is a key component of Arcutis Biotherapeutics valuation and have some predictive power on the future returns of a Arcutis Biotherapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Chemicals Invested over 40 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Impulse Invested over 100 shares | |
 | Blockchain Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Banking Invested over 40 shares | |
 | ESG Investing Invested few shares | |
 | Dividend Beast Invested over 50 shares |
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.